by John Conrad | Oct 16, 2024 | iBIO News
In the heart of the Midwest, a technological revolution is brewing that could transform the landscape of pharmaceutical research. Chicago, long known for its towering skyscrapers and deep-dish pizza, is now poised to become the epicenter of a quantum-powered...
by John Conrad | Sep 17, 2024 | iBIO News
We are thrilled to announce the successful completion of the EPIC (Employer Provided Innovation Challenges) project, an initiative driven by the US Chamber of Commerce Foundation designed to provide students with hands-on, real-world learning experiences. In...
by John Conrad | Sep 10, 2024 | iBIO News, Policy News
iBIO has joined forces with fellow members of the Council of State Bioscience Associations (CSBA) in a crucial initiative to safeguard the future of rare pediatric disease research and treatment. Yesterday, our coalition sent a letter to congressional leaders, urging...
by John Conrad | Sep 9, 2024 | iBIO News
Amy Tomasulo battles trigeminal neuralgia, a rare neurological disorder that inflicts some of the most excruciating pain known to medicine. Diagnosed in 2001, she lives with a condition that affects approximately 400,000 Americans, causing intense, shock-like facial...
by John Conrad | Aug 26, 2024 | iBIO News
The biopharma sector’s performance in Q2 2024 presents a compelling narrative of resilience and adaptation, as revealed by Pitchbook’s latest VC Report. This analysis delves into the sector’s nuanced landscape, highlighting significant trends and...
by John Conrad | Aug 16, 2024 | iBIO News
NewsBrief Weekly News Quiz: August 16th Friday Biotech Blitz: Challenge Your Scientific Acumen 🧬🔬 Calling all biotech buffs! Our weekly iBIO NewsBrief Quiz is here to test your grasp of the latest breakthroughs. This week’s lineup: 5 cutting-edge...
